Usage Patterns of Short-Acting β2-Agonists and Inhaled Corticosteroids in Asthma: A Targeted Literature Review
Authors:
- 1 September 2020
- journal article
- review article
- Published by Elsevier in The Journal of Allergy and Clinical Immunology: In Practice
- Vol. 8 (8) , 2556-2564.e8
Abstract
No abstract availableKeywords
Funding Information
- AstraZeneca
This publication has 41 references indexed in Scilit:
- An evaluation of asthma medication utilization for risk evaluation and mitigation strategies (REMS) in the United States: 2005–2011Journal of Asthma, 2013
- Accuracy of patient self‐report as a measure of inhaled asthma medication useRespirology, 2013
- The risk of asthma exacerbation after stopping low-dose inhaled corticosteroids: A systematic review and meta-analysis of randomized controlled trialsJournal of Allergy and Clinical Immunology, 2013
- Short-acting β-agonist use and its ability to predict future asthma-related outcomesAnnals of Allergy, Asthma & Immunology, 2012
- AdherenceClinics in Chest Medicine, 2012
- Repeated cross-sectional survey of patient-reported asthma control in Europe in the past 5 yearsEuropean Respiratory Review, 2012
- Changes in primary care prescribing patterns for paediatric asthma: a prescribing database analysisArchives of Disease in Childhood, 2011
- Low-Dose Inhaled Corticosteroids and the Prevention of Death from AsthmaNew England Journal of Medicine, 2000
- Patterns of increasing beta-agonist use and the risk of fatal or near-fatal asthmaEuropean Respiratory Journal, 1994
- A Cohort Analysis Of Excess Mortality In Asthma And The Use Of Inhaled Beta-AgonistsAmerican Journal of Respiratory and Critical Care Medicine, 1994